Please assess the completion status of the following clinical trial:

Trial Title: Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed pregnancy (through palpable fundus and/ or positive pregnancy test)~* Gestational age between 16 and 28 weeks.~* Informed consent by patient (or parent/ guardian if patient is less than 18 years of age)~* No symptoms consistent with malaria~* Willingness to deliver at the health facility~* Willingness to adhere to all requirements of the study (including HIV-1 testing)~Exclusion Criteria:~* History of allergy to study drugs, or previous history of allergy to sulpha drugs~* History or presence of major illnesses likely to influence pregnancy outcome including diabetes mellitus, severe renal or heart disease, or active tuberculosis, prior to randomization;~* Any significant illness that requires hospitalization;~* Intent to move out of the study catchment's area before delivery or deliver at relative's home out of the catchment's area;~* Prior enrolment in the study or concurrent enrolment in another study~* Severe anaemia (Hb\<7 g/dl)~* Previous history of unfavourable pregnancy outcome: pre-eclampsia, caesarean section, stillbirth.~* Being HIV infected and already receiving CTX prophylaxis or ARV treatment

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): HIV-negative women taking CTX as chemoprophylaxis
- 2 (Type: ACTIVE_COMPARATOR): HIV-negative women taking SP as IPT
- 3 (Type: EXPERIMENTAL): HIV-positive women (CD4\> 200) taking CTX as chemoprophylaxis
- 4 (Type: ACTIVE_COMPARATOR): HIV-positive women (CD4 \> 200) taking SP as IPT

Based on this trial design, predict the completion outcome and termination type (if applicable).